Overview

• Around 500,000 people in the UK and 12 percent of Americans have tried GLP-1 weight-loss injections as users report craving sweet-smelling perfumes.
• The global market for gourmand fragrances has surged past £24 billion as dessert-like notes such as vanilla, caramel and chocolate fly off shelves.
• Research indicates GLP-1 agonists act on brain regions tied to taste and smell, driving a shift from sugar consumption to sweet-scent indulgence.
• Dermatologists link rapid weight loss and drier skin to a preference for richer, longer-lasting perfumes that also mask new body odours caused by slower digestion.
• Clinicians warn hormonal changes—such as altered cortisol levels—and emerging side effects like ‘Ozempic Mouth’ and ‘Ozempic Feet’ highlight wider sensory and physical impacts.